Method for selecting a permissive cell line for replicating avian viruses

US10053672B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10053672-B2
Application numberUS-201414905485-A
CountryUS
Kind codeB2
Filing dateJul 24, 2014
Priority dateJul 25, 2013
Publication dateAug 21, 2018
Grant dateAug 21, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a method for obtaining an untransformed avian cell line enabling in vitro avian virus replication. Said method includes the following steps: a) culturing avian embryonic stem cells in the presence of a stroma for at least 3 days; b) culturing for at least 2 days in a medium having a low serum concentration; c) culturing for at least 2 days in a medium having a low serum concentration containing 1 to 10 mM of hexamethyleme bisacetamide (HMBA); d) culturing for at least 10 days in a medium having a low serum concentration; and e) culturing or freezing an avian cell line enabling avian virus replication. The invention also relates to the resulting cell line and to the use thereof in vaccine preparations.

First claim

Opening claim text (preview).

The invention claimed is: 1. A vaccinal preparation comprising a non-transformed avian cell line allowing replication of avian viruses in vitro; wherein the non-transformed avian cell line is made by a method comprising: a) cultivating avian embryonic stem cells in the presence of a stroma for at least 3 days; b) cultivating in a medium with a low serum concentration for at least 2 days; c) cultivating in a low serum concentration medium comprising between 1and 10 mM of hexamethylene bisacetamide (HMBA), for at least 2 days; and d) cultivating in a low serum concentration medium for at least 10 days; to thereby provide a non-transformed avian cell line allowing replication of avian viruses, wherein the non-transformed avian cell line expresses the following markers: CD44+, beta1 integrin, collagen 1 and OLFM3; and wherein the non-transformed avian cell line is infected with at least one avian virus.

Assignees

Inventors

Classifications

  • Pluripotent embryonic cells, e.g. embryonic stem cells [ES] (embryonic germ cells C12N5/0611, induced pluripotent stem cells C12N5/0696) · CPC title

  • Keratinocytes; Whole skin · CPC title

  • Cells of skeletal and connective tissues; Mesenchyme · CPC title

  • Organic components · CPC title

  • relating to complementing cells and packaging systems for producing virus or viral particles · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10053672B2 cover?
The present invention relates to a method for obtaining an untransformed avian cell line enabling in vitro avian virus replication. Said method includes the following steps: a) culturing avian embryonic stem cells in the presence of a stroma for at least 3 days; b) culturing for at least 2 days in a medium having a low serum concentration; c) culturing for at least 2 days in a medium having a l…
Who is the assignee on this patent?
Agronomique Inst Nat Rech
What technology area does this patent fall under?
Primary CPC classification C12N7/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).